A patient-derived, autologous technology beginning with the patient’s own platelet-rich plasma collected chair-side and processed in an FDA-registered, cGMP-compliant facility. This category provides a distinct patient-specific option within the CELLXO™ regenerative-biologics portfolio.
Select 1 unit for further instructions and information. One of our representatives will contact you regarding pricing.
EV count: 100B, 200B, 400B
Source: Autologous, platelet derived
Application: Aesthetics